Yazar "Kurtuncu, M." için listeleme
-
CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT
Gul, A.; Demir, G. A.; Kurtuncu, M.; Erer, B.; Sevgi, S.; Turgay, S. (CLINICAL & EXPER RHEUMATOLOGY, 2016)… -
Comparison of dropout rates of disease modifying therapies in multiple sclerosis
Kurtuncu, M.; Celik, S. Yildiz; Coban, A.; Shugaiv, E.; Pehlivan, M.; Akman-Demir, G.; Eraksoy, M. (SAGE PUBLICATIONS LTD, 2014)… -
How long should we treat Neuro-Behcet's disease?
Kurtuncu, M.; Gunduz, T.; Aydin, B. N.; Akman, G. (CLINICAL & EXPER RHEUMATOLOGY, 2018)… -
Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behcet's disease with parenchymal involvement: presentation of four cases
Shugaiv, E.; Tuzun, E.; Mutlu, M.; Kiyat-Atamer, A.; Kurtuncu, M.; Akman-Demir, G. (CLINICAL & EXPER RHEUMATOLOGY, 2011)Background. Behcet's disease is a inultisystemic, relapsing, inflammatory disorder of unknown origin. Among Turkish cohorts, 5-15% of patients show involvement of the central nervous system (CNS) at some time during their ... -
Neuro-behcet's disease: Analysis of 430 patients
Kurtuncu, M.; Aydin, B. N.; Gunduz, T.; Ala, S.; Akman-Demir, G. (ELSEVIER SCIENCE BV, 2017)… -
Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey
Terzi, M.; Kurtuncu, M.; Eraksoy, M.; Karabudak, R.; Tuncer, A.; Altunrende, B.; Terzi, Y. (SAGE PUBLICATIONS LTD, 2016)… -
White matter lesions in Behcet's disease: neuro-Behcet's disease or multiple sclerosis?
Akman-Demir, G.; Mutlu, M.; Kiyat-Atamer, A.; Shugaiv, E.; Kurtuncu, M.; Tugal-Tutkun, I.; Bahar, S. (SAGE PUBLICATIONS LTD, 2012)…
